VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ESTAEstablishment Labs Holdings Inc.
$86.06$2.5B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksESTAP/E History

ESTA logoEstablishment Labs Holdings Inc. (ESTA) P/E Ratio History

Insufficient Data

Insufficient historical P/E data to classify valuation. · Data 2026–2026

Current P/E (TTM)
-50.0x
5Y Avg P/E
N/A
Median N/A
5Y Percentile
N/A
PEG Ratio
N/A
TTM EPS$-1.48
Price$86.06
Earnings YieldN/A
EPS Growth (1Y)42.7%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 23, 2026, Establishment Labs Holdings Inc. (ESTA) trades at a price-to-earnings ratio of -50.0x, with a stock price of $86.06 and trailing twelve-month earnings per share of $-1.48.

Compared to the Healthcare sector median P/E of 22.1x, ESTA trades at a 326% discount to its sector peers. The sector includes 233 companies with P/E ratios ranging from 0.0x to 194.5x.

Relative to the broader market, ESTA trades at a notable discount to the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ESTA DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

ESTA Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-50.0vs22.1
-326%
Below Sector
vs. S&P 500
-50.0vs24.3
-306%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 43% EPS growth (1Y)

ESTA P/E vs Peers

Aesthetics, dermatology, and wound care peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
ALGN logoALGNAlign Technology, Inc.
$12B30.8-+1%
INMD logoINMDInMode Ltd.
$837M9.2Lowest0.94Best-36%
XTNT logoXTNTXtant Medical Holdings, Inc.
$61M14.5-+125%Best
SYK logoSYKStryker Corporation
$117B36.32.46+8%
ZBH logoZBHZimmer Biomet Holdings, Inc.
$17B24.5--20%
BSX logoBSXBoston Scientific Corporation
$66B22.9-+55%
MDT logoMDTMedtronic plc
$102B22.0-+31%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ESTA — Frequently Asked Questions

Quick answers to the most common questions about buying ESTA stock.

What is ESTA's P/E ratio?

Establishment Labs Holdings Inc. (ESTA) trailing twelve-month P/E ratio is -50.0x, based on TTM diluted EPS of $-1.48. The 5-year average P/E is N/A and the historical range spans N/A to N/A.

Is ESTA stock overvalued or undervalued?

ESTA current P/E: -50.0x. 5-year average P/E: N/A. Percentile: N/A.

Is ESTA stock expensive?

ESTA is fairly valued relative to its own history. The current P/E of -50.0x is near the 5-year average of N/A (N/A percentile of historical range).

What is ESTA's historical P/E range?

Over the past 5 years, ESTA's P/E ratio has ranged from N/A to N/A, with a median of N/A and an average of N/A. The current P/E of -50.0x places the stock at the N/A percentile of this range. Full historical data spans 2026–2026.

How does ESTA's P/E compare to the S&P 500?

ESTA trades at -50.0x P/E versus the S&P 500 median of 24.3x. The 306% discount to the market suggests lower growth expectations or perceived higher risk.

How does ESTA's valuation compare to Healthcare peers?

Establishment Labs Holdings Inc. P/E of -50.0x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is ESTA's PEG ratio?

ESTA PEG ratio is N/A, based on a P/E of -50.0x and EPS growth of 42.7%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is ESTA's earnings yield?

ESTA earnings yield is N/A, the inverse of its -50.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

ESTA P/E Ratio History

Quarterly valuation multiple from closing price and trailing EPS

Current-
Period Avg-
Range- - -
Change-
0 quarters- - -